Prevalence of A2143G mutation of H. pylori-23S rRNA in Chinese subjects with and without clarithromycin use history

BMC Microbiology

Volumn 8, Issue , 2008, Pages

  Liu, Zhuoqi ^a,b   Shen, Jing ^a   Zhang, Lian ^a   Shen, Lin ^a   Li, Qiang ^a   Zhang, Baozhen ^a   Zhou, Jing ^a   Gu, Liankun ^a   Feng, Guoshuang ^a   Ma, Junling ^a   You, Wei Cheng ^a   Deng, Dajun ^a  

^a PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

^b NANCHANG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; BACTERIAL RNA; CLARITHROMYCIN; OMEPRAZOLE; RNA 23S; BACTERIAL DNA;

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; CHINESE; CONTROLLED STUDY; DNA EXTRACTION; DRUG USE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE MUTATION; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PREVALENCE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; STOMACH JUICE; UREA BREATH TEST; CHINA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DOUBLE BLIND PROCEDURE; DRUG COMBINATION; GENETICS; MICROBIOLOGY; MIDDLE AGED; POINT MUTATION; RANDOMIZED CONTROLLED TRIAL;

HELICOBACTER PYLORI;

ADULT; AMOXICILLIN; CHINA; CLARITHROMYCIN; DNA MUTATIONAL ANALYSIS; DNA, BACTERIAL; DOUBLE-BLIND METHOD; DRUG RESISTANCE, BACTERIAL; DRUG THERAPY, COMBINATION; FEMALE; GASTRIC JUICE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; OMEPRAZOLE; POINT MUTATION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RNA, RIBOSOMAL, 23S;

EID: 45249091678     PISSN: 14712180     EISSN: 14712180     Source Type: Journal    
DOI: 10.1186/1471-2180-8-81     Document Type: Article

References (27)

1. IARC, Monographs on the evaluation of carcinogenic risks to humans Vol 61. Schistosomes, liver flukes and Helicobacter pylori Lyon, France 1994
2. Campylobacter pyloridis, gastritis and peptic ulceration. CS Goodwin JA Armstring BJ Marshall, J Clin Pathol 1986 39 353 165 3517070 10.1136/jcp.39.4.353
3. Helicobacter pylori gastritis and primary gastric non-Hodgkin's lymphomas. S Edit M Stolte R Fischer, J Clin Pathol 1994 47 436 439 8027397 10.1136/jcp.47.5.436
4. Prevention of gastric cancer: urgent need to implement Helicobacter pylori eradication therapy as a primary preventive measure in Japan. K Sugano, J Gastroenterol 2007 Suppl 17 1 2 10.1007/s00535-006-1941-8
5. Helicobacter pylori eradication for gastric cancer prevention. TK Cheung HHX Xia BCY Wong, J Gastroenterol 2007 Suppl 17 10 15 10.1007/s00535-006-1939-2
6. Indications for Helicobacter pylori eradication therapy and first-line therapy regimen in Japan: recommendation by the Japanese Society for Helicobacter Research. K Satoh, J Gastroenterol 2002 37 Suppl 13 34 38 12109663
7. First line therapy for Helicobacter pylori eradication in France. JL Dupas, Gastroenterol Clin Biol 2003 27 3Pt2 467 472 12700504
8. H pylori antibiotic resistance: prevalence, importance, and advances in testing. F Mégraud, Gut 2004 53 1374 1384 15306603 10.1136/gut.2003. 022111
9. Helicobacter pylori and antimicrobial resistance: molecular mechanisms and clinical implications. MM Gerrits AHM van Vliet EJ Kuipers JG Kusters, Lancet Infect Dis 2006 6 11 699 709 17067919 10.1016/S1473-3099(06)70627-2
10. Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions. WC You LM Brown L Zhang JY Li ML Jin YS Chang JL Ma KF Pan WD Liu Y Hu S Crystal-Mansour D Pee WJ Blot JF Fraumeni GW Xu MH Gail, J Natl Cancer Inst 2006 98 974 983 16849680
11. Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori. J Versalovic D Shortridge K Kibler MV Griffy J Beyer RK Flamm SK Tanaka DY Graham MF Go, Antimicrob Agents Chemother 1996 40 477 480 8834903
12. A PCR-oligonucleotide ligation assay to determine the prevalence of 23S rRNA gene mutations clarithromycin-resistant Helicobacter pylori. GG Stone D Shortridge J Versalovic J Beyer RK Flamm DY Graham AT Ghoneim SK Tanaka, Antimicrob Agents Chemother 1997 41 712 714 9056021
13. Formation of A2143G mutation of 23S rRNA in progression of clarithromycin-resistance in Helicobacter pylori 26695. J Shen J-Z Zhang Y Ke D Deng, Microb Drug Resist 2005 11 100 106 10.1089/mdr.2005.11.100 15910222
14. Assessment of clarithromycin-resistant Helicobacter pylori among patients in Shanghai and Guangzhou, China, by primer-mismatch PCR. ZJ Pan WW Su GN Tytgat J Dankert A van der Ende, J Clin Microbiol 2002 40 259 261 11773126 10.1128/JCM.40.1.259-261.2002
15. The prevalence and mechanism of Helicobacter pylori resistance to clarithromycin in Beijing. X Zheng F Hu W Wang, Zhonghua YiXue ZaZhi 2001 81 1413 1415 11930609
16. Prevalence and mechanism of Helicobacter pylori resistance to clarithromycin in children. J Chen JD Yu XL Huang FB Chen ZY Li XP Zhang, Zhonghua Er Ke Za Zhi 2004 42 850 853 15631715
17. Secondary resistance among 554 isolates of Helicobacter pylori after failure of therapy. M Heep M Kist S Strobel D Beck N Lehn, Eur J Clin Microbiol Infect Dis 2000 19 538 541 10.1007/s100960000288 10968325
18. Helicobacter pylori specific nested PCR assay for the detection of 23S rRNA mutation associated with clarithromycin resistance. S Maeda H Yoshida K Ogura F Kanai Y Shiratori M Omata, Gut 1998 43 317 321 9863474
19. PCR-based RFLP analysis of DNA sequence diversity in the gastric pathogen Helicobacter pylori. N Akopyanz NO Bukanov TU Westblom DE Berg, Nucleic Acids Res 1992 20 6221 6225 1361982 10.1093/nar/20.23.6221
20. Diagnosis of Helicobacter pylori infection. KA Krogfelt P Lehours F Megraud, Helicobacter 2005 Suppl 1 5 13 10.1111/j.1523-5378.2005.00341.x
21. Review article: invasive and non-invasive tests for Helicobacter pylori infection. D Vaira J Holton M Menegatti C Ricci L Gatta A Geminiani M Miglioli, Aliment Pharmacol Ther 2000 Suppl 3 13 22 10.1046/j.1365-2036.2000.00096.x
22. Prevalence and rapid identification of clarithromycin-resistant Helicobacter pylori isolates in children. YJ Yang JC Yang YM Jeng MH Chang YH Ni, Pediatr Infect Dis J 2001 20 662 666 10.1097/00006454-200107000-00005 11465837
23. Diversity of domain V of 23S rRNA gene sequence in different enterococcus species. S Tsiodras HS Gold EPG Coakley C Wennersten RC Moellering GM Eliopoulos, J Clin Microbiol 2000 38 3991 3993 11060057
24. Erythromycin resistance by ribosome modification. B Weisblum, Antimicrob Agents Chemother 1995 39 577 585 7793855
25. Helicobacter pylori infection, garlic intake and precancerous lesions in a Chinese population at low risk of gastric cancer. WC You L Zhang MH Gail JL Ma YS Chang WJ Blot JY Li CL Zhao WD Liu HQ Li YR Hu JC Bravo P Correa GW Xu JF Fraumeni, Int J Epidemiol 1998 27 941 944 10.1093/ije/27.6.941 10024185
26. Eradication of H pylori infection in a rural population: one-day quadruple therapy versus 7-day triple therapy. L Zhang L Shen JL Ma KF Pan WD Liu J Li SD Xiao SR Lin M Classen WC You, World J Gastroenterol 2006 12 3915 3918 16804982
27. Helicobacter pylori specific nested PCR assay for the detection of 23S rRNA mutation associated with clarithromycin resistance. S Maeda H Yoshida K Ogura F Kanai Y Shiratori M Omata, Gut 1998 43 317 321 9863474